Founded in 2023 and based in Shanghai, China, Allink Biotherapeutics is a biotech company dedicated to expediting the development of a diverse pipeline of FIC/BIC therapeutic candidates for oncology and immune diseases.
Our goal is to harness our proprietary bispecific antibody and ADC technology platforms, along with efficient execution and business collaboration to address critical unmet clinical needs.
Company Details
- Employees
- 9
- Founded
- 2023
- Address
- Shanghai, Cn
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.allinkbio.com/
- HQ
- Shanghai
Allink Biotherapeutics Questions
Allink Biotherapeutics's website is http://www.allinkbio.com/
Allink Biotherapeutics's LinkedIn profile is https://cn.linkedin.com/company/allinkbio
Allink Biotherapeutics has
9 employees.
View email and phone details for 9
employees at Allink Biotherapeutics.
Allink Biotherapeutics's industry is
Biotechnology Research
Allink Biotherapeutics's top competitors are
Antag Therapeutics,
Serina Therapeutics, Inc.,
Shanghai Junshi Biosciences Co Ltd,
The Antibody Society,
Transcode Therapeutics, Inc.,
Senti Biosciences,
Velavigo,
Olema Oncology,
Edigene Inc.,
Chengdu Kanghong Pharmaceutical Group Co.,ltd..
Allink Biotherapeutics's categories are Biotechnology Research
Allink Biotherapeutics's founding year is 2023
